CIPLA vs SUNPHARMA: Which Is Better on the Numbers?
Cipla Ltd (CIPLA) trades at ₹1397 on a P/E of 29.7, while Sun Pharmaceutical Industries Ltd (SUNPHARMA) trades at ₹1793 on a P/E of 34.3. On valuation, Cipla Ltd is cheaper on earnings (P/E 29.7 vs 34.3). This is a data comparison, not a recommendation.
CIPLA vs SUNPHARMA — full comparison
| Metric | CIPLA | SUNPHARMA |
|---|---|---|
| Share price | ₹1,396.7 | ₹1,793 |
| P/E ratio (lower = cheaper) | 29.70 | 34.30 |
| ROE (higher = better) | 11.60% | 16.00% |
| ROCE (higher = better) | 15.50% | 20.50% |
| Dividend yield | 0.93% | 0.90% |
| Annualised return (history) | -4.8% | +8.6% |
| Volatility (lower = steadier) | 22% | 20% |
| 1-year forecast (Monte Carlo median) | ₹1,291.7 | ₹1,916.97 |
| Cheapest MTF margin | 22% (Dhan) | 22% (Dhan) |
How CIPLA and SUNPHARMA compare
- On valuation, Cipla Ltd is cheaper on earnings (P/E 29.7 vs 34.3).
- On profitability, Sun Pharmaceutical Industries Ltd earns a higher return on equity (ROE 16.0% vs 11.6%).
- For income, Cipla Ltd pays a higher dividend yield (0.93% vs 0.90%).
- On recent momentum, Sun Pharmaceutical Industries Ltd has the stronger annualised return (+8.6% vs -4.8%).
- On risk, Sun Pharmaceutical Industries Ltd has been less volatile (annualised volatility 20% vs 22%).
Not investment advice. This page compares publicly available metrics and a statistical forecast for information only. The 1-year forecast is a Monte Carlo projection from historical volatility, not a prediction. Do your own research or consult a SEBI-registered adviser before investing.
More stock comparisons
INFY vs TCSTCS vs WIPROINFY vs WIPROHCLTECH vs TCSHCLTECH vs INFYHCLTECH vs WIPROINFY vs TECHMHDFCBANK vs ICICIBANKHDFCBANK vs SBINICICIBANK vs SBINHDFCBANK vs KOTAKBANKAXISBANK vs ICICIBANKAXISBANK vs SBINAXISBANK vs KOTAKBANKAXISBANK vs HDFCBANKADANIENT vs RELIANCEMARUTI vs TATAMOTORSBAJAJ-AUTO vs HEROMOTOCOEICHERMOT vs TATAMOTORSDRREDDY vs SUNPHARMACIPLA vs DRREDDYCIPLA vs DIVISLABJSWSTEEL vs TATASTEELJINDALSTEL vs TATASTEEL
Related tools
- CIPLA MTF margins & research
- SUNPHARMA MTF margins & research
- Stock screener — filter by P/E, ROE and 30+ metrics
- Stock valuation — estimate intrinsic value
- Nifty PE tracker — market-wide valuation context